ArticleInternational ophthalmology2025
Pars plana vitrectomy combined with expanded area retinal photocoagulation for treatment of rhegmatogenous retinal detachment with inferior breaks.
Article in International ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo evaluate the clinical efficacy of pars plana vitrectomy (PPV) combined with expanded-area retinal photocoagulation for the treatment of primary retinal detachment with inferior breaks.
methodsEighteen patients (18 eyes) with primary retinal detachment due to inferior breaks, treated at our institute between January 2020 and October 2023, were retrospectively analyzed. All patients underwent 23-gauge PPV combined with expanded-area retinal photocoagulation. The patients' best corrected visual acuity (BCVA) and intraocular pressure (IOP) were measured preoperatively and 6 months post-operatively, along with assessments for retinal redetachment, epiretinal membrane formation, and complications.
resultsThe BCVA (LogMAR) significantly improved from 0.78 ± 0.69 preoperatively to 0.31 ± 0.20 after 6 months (t = 3.374, P < 0.01). None of the treated eyes developed retinal detachment during the follow-up period. No intraoperative complications such as lens injury, hemorrhage, or retinal perforation were reported. During the postoperative follow-up period, no cases of macular puckering, cystoid macular edema, secondary glaucoma, or endophthalmitis were observed.
conclusionPPV combined with expanded-area retinal photocoagulation is an effective treatment for primary retinal detachment with inferior breaks, offering good postoperative visual recovery, low risk of retinal redetachment, and few complications.
Indexed as
Identifiers
40658282What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.